Acticor Biotech (ALACT.PA) Stock Price
Acticor Biotech Price
Revenue has compounded at 5.3% per year over the past 10 years to 4.03 M EUR. Earnings per share have grown at 85.1% per year over the last 5 years. Acticor Biotech's net margin stands at -144.1%, down from -4.9% several years earlier.
Acticor Biotech stock price
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Acticor Biotech business model & stock analysis
Frequently asked questions about Acticor Biotech
9 analysts currently rate the Acticor Biotech stock: 8 recommend buying, 1 holding and 0 selling. For 2026, analysts expect Acticor Biotech to generate revenue of 22.66 M EUR and earnings per share of 1.18 EUR.
The Acticor Biotech share (ALACT.PA) is listed on 4 stock exchanges, including: Frankfurt (7V7.F), München (7V7.MU), Paris (ALACT.PA).
The expected revenue of Acticor Biotech is 22.66 M EUR. This figure is based on current financial data and reflects the company's business performance.
The expected profit of Acticor Biotech is 14.28 M EUR. The net profit reflects the company's profitability after deducting all expenses.
The P/E ratio cannot be calculated for Acticor Biotech at the moment.
The P/S cannot be calculated for Acticor Biotech currently.
The Eulerpool Quality Score for Acticor Biotech is 1/10.
The ISIN of Acticor Biotech is FR0014005OJ5. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The WKN of Acticor Biotech is A3C6GM. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.
The ticker of Acticor Biotech is ALACT.PA. The ticker symbol is used to trade Acticor Biotech shares on the stock exchange.
Acticor Biotech stock
Acticor Biotech Peer Group
Acticor Biotech Ticker
Acticor Biotech FIGI
All fundamentals and in-depth analysis of Acticor Biotech
Our stock analysis for Acticor Biotech stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Acticor Biotech. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.